Imaging genetics and the power of combined technologies: A perspective from neuroethics

Neuroscience

Volumn 164, Issue 1, 2009, Pages 7-15

  Tairyan, K ^a   Illes, J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Genetics; Imaging genetics; Neuroethics; Neuroimaging; Public health

Indexed keywords

ETHICS; GENETIC PROCEDURES; GENETICS; HUMAN; METHODOLOGY; NEUROLOGY; PSYCHIATRY; PUBLIC HEALTH; REVIEW;

GENETIC TECHNIQUES; GENETICS; HUMANS; NEUROLOGY; PSYCHIATRY; PUBLIC HEALTH;

EID: 74049146363     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.052     Document Type: Review

References (78)

1. Annas G.J. Foreword: imagining a new era of neuroimaging, neuroethics, and neurolaw. Am J Law Med 2007, 33:163-170.
2. Ashcroft R.E. Scientific or social priorities for brain science?. making a difference. Nutr Health 2007, 19:135-137.
3. Beauchamp T., Childress J. Principles of biomedical ethics 2001, Oxford University Press, Oxford.
4. Blasi G., Bertolino A. Imaging genomics and response to treatment with antipsychotics in schizophrenia. NeuroRx 2006, 3:117-130.
5. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000, 343:450-456.
6. Borgwardt S.J., Fusar-Poli P. Imaging genomics-an integrative approach to understand the biological susceptibility for schizophrenia. Med Hypotheses 2007, 68:1426.
7. Brocki K., Fan J., Fossella J. Placing neuroanatomical models of executive function in a developmental context: imaging and imaging-genetic strategies. Ann N Y Acad Sci 2008, 1129:246-255.
8. Medical imaging in Canada 2008, Canadian Institute for Health Information, CIHI, Ottawa, Ont, 2007.
9. Congdon E., Canli T. The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches. Behav Cogn Neurosci Rev 2005, 4:262-281.
10. Couzin J. Genetic privacy. Whole-genome data not anonymous, challenging assumptions. Science 2008, 321:1278.
11. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J.P., Angermeyer M.C., Bernert S., de Girolamo G., Morosini P., Polidori G., Kikkawa T., Kawakami N., Ono Y., Takeshima T., Uda H., Karam E.G., Fayyad J.A., Karam A.N., Mneimneh Z.N., Medina-Mora M.E., Borges G., Lara C., de Graaf R., Ormel J., Gureje O., Shen Y., Huang Y., Zhang M., Alonso J., Haro J.M., Vilagut G., Bromet E.J., Gluzman S., Webb C., Kessler R.C., Merikangas K.R., Anthony J.C., Von Korff M.R., Wang P.S., Brugha T.S., Aguilar-Gaxiola S., Lee S., Heeringa S., Pennell B.E., Zaslavsky A.M., Ustun T.B., Chatterji S. Prevalence severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004, 291:2581-2590. WHO World Mental Health Survey Consortium.
12. Dumit J. Picturing personhood: brain scans and biomedical identity 2004, University Press, Princeton, NJ.
13. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
14. Fins J.J., Shapiro Z.E. Neuroimaging and neuroethics: clinical and policy considerations. Curr Opin Neurol 2007, 20:650-654.
15. Fleming E.S., Perkins J., Easa D., Conde J.G., Baker R.S., Southerland W.M., Dottin R., Benabe J.E., Ofili E.O., Bond V.C., McClure S.A., Sayre M.H., Beanan M.J., Norris K.C. Addressing health disparities through multi-institutional multidisciplinary collaboratories. Ethn Dis 2008, 18. S2-161-167.
16. Foster M.W., Royal C.D., Sharp R.R. The routinisation of genomics and genetics: implications for ethical practices. J Med Ethics 2006, 32:635-638.
17. Fraser D.W. Overlooked opportunities for investing in health research and development. Bull WHO 2000, 78:1054-1061.
18. Fuchs T. Ethical issues in neuroscience. Curr Opin Psychiatry 2006, 19:600-607.
19. Fukushi T., Sakura O., Koizumi H. Ethical considerations of neuroscience research: the perspectives on neuroethics in Japan. Neurosci Res 2007, 57:10-16.
20. Fulda K.G., Lykens K. Ethical issues in predictive genetic testing: a public health perspective. J Med Ethics 2006, 32:143-147.
21. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62:146-152.
22. Hariri A.R., Drabant E.M., Weinberger D.R. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 2006, 59:888-897.
23. Hariri A.R., Weinberger D.R. Imaging genomics. Br Med Bull 2003, 65:259-270.
24. Hirsch J. Raising consciousness. J Clin Invest 2005, 115:1102.
25. Hjorleifsson S., Schei E. Scientific rationality, uncertainty and the governance of human genetics: an interview study with researchers at DeCODE Genetics. Eur J Hum Genet 2006, 14:802-808.
26. Illes J. Neuroethics, neurochallenges: a needs-based research agenda 2006, Society for Neuroscience annual meeting, Atlanta, Georgia.
27. Illes J. "Pandora's box" of incidental findings in brain imaging research. Nat Clin Pract Neurol 2006, 2:60-61.
28. Illes J. Neuroethics in a new era of neuroimaging. AJNR Am J Neuroradiol 2003, 24:1739-1741.
29. Illes J., Atlas S. Risks and benefits of the new medical imaging enterprise. Am Med Assoc J Ethics Virtual Mentor 2007, 9:99.
30. Illes J., De Vries R., Cho M.K., Schraedley-Desmond P. ELSI priorities for brain imaging. Am J Bioeth 2006, 6:W24-W31.
31. Illes J., Chin V.N. Bridging philosophical and practical implications of incidental findings in brain research. J Law Med Ethics 2008, 36:298-304.
32. Illes J., Kann D., Karetsky K., Letourneau P., Raffin T.A., Schraedley-Desmond P., Koenig B.A., Atlas S.W. Advertising patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Arch Intern Med 2004, 164:2415-2419.
33. Illes J., Kirschen M. New prospects and ethical challenges for neuroimaging within and outside the health care system. AJNR Am J Neuroradiol 2003, 24:1932-1934.
34. Illes J., Kirschen M.P., Edwards E., Bandettini P., Cho M.K., Ford P.J., Glover G.H., Kulynych J., Macklin R., Michael D.B., Wolf S.M., Grabowski T., Seto B. Practical approaches to incidental findings in brain imaging research. Neurology 2008, 70:384-390.
35. Illes J., Lau P.W., Giacino J.T. Neuroimaging impaired states of consciousness, and public outreach. Nat Clin Pract Neurol 2008, 4:542-543.
36. Illes J., Kirschen M.P., Gabrieli J.D. From neuroimaging to neuroethics. Nat Neurosci 2003, 6:205.
37. Illes J., Racine E. Imaging or imagining?. A neuroethics challenge informed by genetics. Am J Bioeth 2005, 5:5-18.
38. Illes J., Suchowersky O. Appealing to the restless consumer. Nat Clin Pract Neurol 2008, 4:117.
39. Kaiser J. Making clinical data widely available. Science 2008, 322:217-218.
40. Koenig B. Biomedicine examined. Imperative in medical practice: the social creation of a "routine" treatment 1988, 465-496. Kluwer, Boston. M. Lock, D. Gordon (Eds.).
41. Laureys S., Boly M. The changing spectrum of coma. Nat Clin Pract Neurol 2008, 4:544-546.
42. Mattay V.S., Goldberg T.E. Imaging genetic influences in human brain function. Curr Opin Neurobiol 2004, 14:239-247.
43. McGee G. Pragmatic bioethics 2003, MIT Press, Cambridge, MA.
44. Merson M., Black R., Mills A. International public health: diseases programs, systems and polices 2006, Jones & Bartlett Publishing, Sudbury, MA.
45. Meyer-Lindenberg A., Nicodemus K.K., Egan M.F., Callicott J.H., Mattay V., Weinberger D.R. False positives in imaging genetics. Neuroimage 2008, 40:655-661.
46. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7:818-827.
47. Milstein A.C. Research malpractice and the issue of incidental findings. J Law Med Ethics 2008, 36:356-360.
48. Miranda J., McGuire T.G., Williams D.R., Wang P. Mental health in the context of health disparities. Am J Psychiatry 2008, 165:1102-1108.
49. Mitterschiffthaler M.T., Ettinger U., Mehta M.A., Mataix-Cols D., Williams S.C. Applications of functional magnetic resonance imaging in psychiatry. J Magn Reson Imaging 2006, 23:851-861.
50. Morley K.I., Hall W.D., Carter L. Genetic screening for susceptibility to depression: can we and should we?. Aust N Z J Psychiatry 2004, 38:73-80.
51. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008, 63:852-857.
52. Racine E. Interdisciplinary approaches for a pragmatic neuroethics. Am J Bioeth 2008, 8:52-53.
53. Racine E. Discourse ethics as an ethics of responsibility: comparison and evaluation of citizen involvement in population genomics. J Law Med Ethics 2003, 31:390-397.
54. Racine E., Bar-Ilan O., Illes J. fMRI in the public eye. Nat Rev Neurosci 2005, 6:159-164.
55. Racine E., Gareau I., Doucet H., Laudy D., Jobin G., Schraedley-Desmond P. Hyped biomedical science or uncritical reporting?. Press coverage of genomics (1992-2001) in Quebec. Soc Sci Med 2006, 62:1278-1290.
56. Racine E., Illes J. Neuroethical responsibilities. Can J Neurol Sci 2006, 33:269-277.
57. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A 2001, 98:3334-3339.
58. Reiman E.M. Linking brain imaging and genomics in the study of Alzheimer's disease and aging. Ann N Y Acad Sci 2007, 1097:94.
59. Richardson H.S. Incidental findings and ancillary-care obligations. J Law Med Ethics 2008, 36:256-270.
60. Ringman J.M. What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review. J Geriatr Psychiatry Neurol 2005, 18:228-233.
61. Roffman J.L., Weiss A.P., Goff D.C., Rauch S.L., Weinberger D.R. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia. Harv Rev Psychiatry 2006, 14:78-91.
62. Romeo-Malanda S., Nicol D. Protection of genetic data in medical genetics: a legal analysis in the European context. Law Hum Genome Rev 2007, 27:97-134.
63. Roskies A.L. Neuroethics beyond genethics. Despite the overlap between the ethics of neuroscience and genetics, there are important areas where the two diverge. EMBO Rep 2007, 8:S52-S56.
64. Ryu E.K., Chen X. Development of Alzheimer's disease imaging agents for clinical studies. Front Biosci 2008, 13:777-789.
65. Sankar P., Cho M.K., Condit C.M., Hunt L.M., Koenig B., Marshall P., Lee S.S., Spicer P. Genetic research and health disparities. JAMA 2004, 291:2985-2989.
66. Schiff N.D., Rodriguez-Moreno D., Kamal A., Kim K.H., Giacino J.T., Plum F., Hirsch J. fMRI reveals large-scale network activation in minimally conscious patients. Neurology 2005, 64:514-523.
67. Spielman R.S., Bastone L.A., Burdick J.T., Morley M., Ewens W.J., Cheung V.G. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007, 39:226-231.
68. Storey J.D., Madeoy J., Strout J.L., Wurfel M., Ronald J., Akey J.M. Gene-expression variation within and among human populations. Am J Hum Genet 2007, 80:502-509.
69. van Berckel B.N., Scheltens P. Getting a grip on Alzheimer's disease: imaging amyloid in the brain. Lancet Neurol 2007, 6:204-206.
70. Veatch R. The basics of bioethics 2003, Prentice-Hall, Upper Saddle River, NJ.
71. Viding E., Williamson D.E., Hariri A.R. Developmental imaging genetics: challenges and promises for translational research. Dev Psychopathol 2006, 18:877-892.
72. Wachbroit R. The question not asked: the challenge of pleiotropic genetic tests. Kennedy Inst Ethics J 1998, 8:131-144.
73. Warnecke R.B., Oh A., Breen N., Gehlert S., Paskett E., Tucker K.L., Lurie N., Rebbeck T., Goodwin J., Flack J., Srinivasan S., Kerner J., Heurtin-Roberts S., Abeles R., Tyson F.L., Patmios G., Hiatt R.A. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 2008, 98:1608-1615.
74. Wolf S.M., Kahn J.P., Wagner J.E. Using preimplantation genetic diagnosis to create a stem cell donor: issues guidelines and limits. J Law Med Ethics 2003, 31:327-339.
75. Wolf S.M., Lawrenz F.P., Nelson C.A., Kahn J.P., Cho M.K., Clayton E.W., Fletcher J.G., Georgieff M.K., Hammerschmidt D., Hudson K., Illes J., Kapur V., Keane M.A., Koenig B.A., Leroy B.S., McFarland E.G., Paradise J., Parker L.S., Terry S.F., Van Ness B., Wilfond B.S. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 2008, 36:219-248.
76. The world health report 2000: health systems: improving performance 2000, World Health Organization.
77. Xu K., Ernst M., Goldman D. Imaging genomics applied to anxiety stress response, and resiliency. Neuroinformatics 2006, 4:51-64.
78. Zhang W., Dolan M.E. Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populations. Pharmacogenomics 2008, 9:489-492.